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ABSTRACT Microbes must assimilate carbon to grow and colonize their niches. Transcript profiling has suggested that Candida
albicans, a major pathogen of humans, regulates its carbon assimilation in an analogous fashion to the model yeast Saccharomy-
ces cerevisiae, repressing metabolic pathways required for the use of alterative nonpreferred carbon sources when sugars are
available. However, we show that there is significant dislocation between the proteome and transcriptome in C. albicans. Glu-
cose triggers the degradation of the ICL1 and PCK1 transcripts in C. albicans, yet isocitrate lyase (Icl1) and phosphoenolpyru-
vate carboxykinase (Pck1) are stable and are retained. Indeed, numerous enzymes required for the assimilation of carboxylic and
fatty acids are not degraded in response to glucose. However, when expressed in C. albicans, S. cerevisiae Icl1 (ScIcl1) is sub-
jected to glucose-accelerated degradation, indicating that like S. cerevisiae, this pathogen has the molecular apparatus required
to execute ubiquitin-dependent catabolite inactivation. C. albicans Icl1 (CaIcl1) lacks analogous ubiquitination sites and is sta-
ble under these conditions, but the addition of a ubiquitination site programs glucose-accelerated degradation of CaIcl1. Also,
catabolite inactivation is slowed in C. albicans ubi4 cells. Ubiquitination sites are present in gluconeogenic and glyoxylate cycle
enzymes from S. cerevisiae but absent from their C. albicans homologues. We conclude that evolutionary rewiring of ubiquiti-
nation targets has meant that following glucose exposure, C. albicans retains key metabolic functions, allowing it to continue to
assimilate alternative carbon sources. This metabolic flexibility may be critical during infection, facilitating the rapid coloniza-
tion of dynamic host niches containing complex arrays of nutrients.
IMPORTANCE Pathogenic microbes must assimilate a range of carbon sources to grow and colonize their hosts. Current views
about carbon assimilation in the pathogenic yeast Candida albicans are strongly influenced by the Saccharomyces cerevisiae par-
adigm in which cells faced with choices of nutrients first use energetically favorable sugars, degrading enzymes required for the
assimilation of less favorable alternative carbon sources. We show that this is not the case in C. albicans because there has been
significant evolutionary rewiring of the molecular signals that promote enzyme degradation in response to glucose. As a result,
this major pathogen of humans retains enzymes required for the utilization of physiologically relevant carbon sources such as
lactic acid and fatty acids, allowing it to continue to use these host nutrients even when glucose is available. This phenomenon
probably enhances efficient colonization of host niches where sugars are only transiently available.
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Carbon assimilation is fundamentally important for all organ-isms. When faced with choices of carbon source, microbes
often assimilate preferred carbon sources to support the first
phase of growth and then, having exhausted these carbon sources,
turn to alternative energetically less favorable carbon sources to
drive subsequent phases of diauxic growth. This selective carbon
utilization is reflected in the differential regulation of genes and
enzymes that support the uptake and catabolismof specific carbon
sources. The Escherichia coli lac operon provides a classic example
of this, mediating lactose utilization only after the preferred car-
bon source, glucose, is exhausted (1, 2). In Saccharomyces cerevi-
siae, glucose limits the assimilation of alternative carbon sources
and represses respiration under aerobic conditions, promoting
fermentative metabolism (the Crabtree effect [3, 4]).
S. cerevisiae is exquisitely sensitive to sugars: even glucose con-
centrations as low as 0.01% trigger the major redirection of cellu-
lar resources (5, 6). Glucose exerts its dramatic effects upon
S. cerevisiae physiology via signaling pathways that include the
glucose repression (Snf1 AMP kinase) pathway, cyclic AMP
(cAMP)-protein kinaseA signaling, and the sugar receptor repres-
sor (Snf3-Rgt2) pathway (for reviews, see references 7 to 12). The
cAMP-protein kinase A pathway activates ribosome biogenesis
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and downregulates stress responses in response to glucose (13–
16). The sugar receptor repressor pathway modulates the expres-
sion of hexose transporters (9, 17, 18). Meanwhile, the glucose
repression pathway represses the transcription of genes involved
in the assimilation of alternative carbon sources, such as galactose,
ethanol, and fatty acids (7, 8).
These sugar signaling mechanisms comprise an interlinked
network rather than parallel signaling pathways (8, 10, 12, 18, 19).
Furthermore, glucose regulation is imposed at multiple levels in
S. cerevisiae. They include transcriptional (7–9), posttranscrip-
tional (5, 6, 20, 21), translational (22), and posttranslational
mechanisms (23–28). For example, glucose represses the tran-
scription of genes encoding the gluconeogenic enzymes fructose
1,6-bisphosphatase (FBP1) and phosphoenolpyruvate carboxyki-
nase (PCK1) (29, 30) and triggers the accelerated degradation of
the FBP1 and PCK1mRNAs (5, 20). Furthermore, glucose triggers
the phosphorylation and inactivation of fructose 1,6-
bisphosphatase (Fbp1) as well as its proteolytic degradation (31).
The accelerated degradation of Fbp1 is mediated by vacuolar and
ubiquitin-dependent mechanisms (28). Following glucose addi-
tion, Fbp1 is ubiquitinated and degraded via the proteasome (25,
28, 32). Like Fbp1, the glyoxylate cycle enzyme, isocitrate lyase
(Icl1) is also subject to catabolite inactivation in S. cerevisiae (24).
This tight control of central carbon metabolism is thought to re-
flect the evolution of thismodel yeast under conditions of “feast or
famine” and to enhance the competitiveness of S. cerevisiae in
sugar-rich niches containing complex microflora (9).
S. cerevisiae is often viewed as a paradigm for other yeasts (33).
However, yeast species inhabit diverse niches and have evolved
under contrasting selective pressures leading to differing strategies
of carbon utilization (34). For example, themajor systemic fungal
pathogen of humans, Candida albicans, inhabits niches that con-
tain complex mixtures of carbon sources. During commensalism
andmucosal infection,C. albicans colonizes the oral cavity and the
gastrointestinal and urogenital tracts, and during systemic infec-
tion, this pathogen can thrive in the bloodstream and most inter-
nal organs (35, 36). Few of these niches are rich in sugar. Blood
glucose levels range from 4 to 7 mM (0.07 to 0.13%), whereas
concentrations of about 111 mM (2%) are often used to impose
glucose repression in in vitro experiments.Many niches are rich in
alternative carbon sources, such as lactate, fatty acids, and amino
acids. For example, lactic acid is found in ingested foods, is pro-
duced by host metabolic activity and by lactic acid bacteria in the
gastrointestinal and urogenital tracts (37), and is essential for the
proliferation of Candida glabrata in the intestinal tract (38). Also,
glyoxylate cycle and fatty acid -oxidation genes are expressed in
the host and are required for the full virulence of C. albicans dur-
ing systemic infections (39–42).
Although C. albicans occupies contrasting niches from
S. cerevisiae, analogous sugar signaling pathways are thought to
exist in these yeasts (33). Although there has been considerable
rewiring of the regulatory circuitry that controls carbon metabo-
lism (43–45), microarray experiments have revealed that C. albi-
cans genes involved in the assimilation of alternative carbon
sources are exquisitely sensitive to low concentrations of glucose
(46, 47), like their orthologs in S. cerevisiae (6). However, unlike
S. cerevisiae, C. albicans continues to respire in the presence of
glucose, leading to its classification as a Crabtree-negative yeast
(48).
These observations create an interesting conundrum relating
to the carbon assimilation and pathogenicity of C. albicans: how
can this yeast rapidly colonize niches that contain small amounts
of glucose if many of the metabolic genes required for efficient
growth in these niches are repressed by glucose? Could glucose
regulation be relaxed at a posttranscriptional level in C. albicans,
thereby facilitating simultaneous assimilation of sugars and alter-
native carbon sources in vivo? We have addressed these questions
first by performing proteomic screens to identify proteins that are
regulated in response to physiologically relevant carbon sources,
revealing that gluconeogenic and glyoxylate cycle enzymes remain
at high levels hours after glucose exposure. We then showed that
C. albicans Pck1 and Icl1 are not destabilized by glucose, in con-
trast to S. cerevisiae Pck1 and Icl1, even though C. albicans has
retained the molecular apparatus to program the accelerated,
ubiquitin-mediated degradation of target proteins following glu-
cose exposure. C. albicans Icl1 escapes degradation following glu-
cose addition, because this enzyme lacks key ubiquitination sites
required to target it for accelerated degradation. Our data show
that there has been significant posttranscriptional rewiring during
the evolution of this pathogen, thereby allowing C. albicans to
continue to assimilate alternative carbon sources in the presence
of glucose.
RESULTS
Carbon source has amajor impact on theC. albicans proteome.
Microarray studies have shown that the C. albicans transcriptome
is exquisitely sensitive to glucose and that genes involved in the
assimilation of alternative carbon sources are subject to glucose
repression (46, 47). Our first aim was to establish whether this
transcriptional regulation was reflected in the C. albicans pro-
teome. To test this, we grewprototrophicC. albicansNGY152 cells
(see Table S1 in the supplemental material) for 20 h in minimal
medium containing glucose, lactate, oleate, or amino acids as the
sole carbon source, harvested them in mid-exponential phase,
prepared protein extracts, and subjected them to two-
dimensional (2D) gel electrophoresis (Materials and Methods).
Principal component analysis confirmed the reproducibility of
the 2D gels from the independent replicate experiments and
showed that the carbon source had a significant impact upon the
C. albicans proteome (see Fig. S1A in the supplemental material).
Proteins that displayed statistically significant changes in level on
the basis of three independent experiments (Fig. 1A) were identi-
fied by tryptic digestion and matrix-assisted laser desorption ion-
ization–time of flight (MALDI-ToF) mass spectrometry. Positive
identifications were obtained for 206 2D gel features, representing
152 different C. albicans proteins, some distinct features repre-
senting isoforms of the same protein. The list of C. albicans pro-
teins identified is presented in Table S2 and submitted to the
PRIDE (proteomics identifications database) proteomic data re-
pository (http://www.ebi.ac.uk/pride/) (accession numbers 3186
to 3192).
The network of proteins that displayed statistically significant
changes in response to carbon sourcemainly comprisedmetabolic
enzymes (Fig. 1B). Significant overlap was observed between the
sets of proteins that were regulated in response to growth on lac-
tate, oleate, or amino acids compared to the glucose condition.
During growth on these organic acids, glycolytic enzymes were
downregulated, and enzymes involved in gluconeogenesis, the
glycoxylate cycle, the tricarboxylic acid (TCA) cycle and pathways
involved in the assimilation of alternative carbon sources were
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upregulated (Fig. 1B and 2B; see Fig. S2 in the supplemental ma-
terial). For example, gluconeogenic (Pck1 and Fbp1) and tricar-
boxylic acid cycle enzymes (Aco1, Kgd1, and Mdh11) displayed
reduced levels, and the glycolysis-specific enzyme pyruvate kinase
(Cdc19) was at elevated levels (see Fig. S2 and Table S2 in the
supplemental material) during growth on glucose compared to
lactate-, oleic acid-, and amino acid-grown cells. During growth
on oleate, fatty acid-oxidation (Faa21/23/24, Fox2, Pot11, Pox4,
and Tes1), glyoxylate cycle (Icl1), and additional TCA cycle en-
zymes (Cit1 and Fum11) were present at elevated levels compared
to the levels in glucose-grown cells (Fig. 2; Table S2). Enzymes on
many amino acid biosynthetic pathwayswere downregulated dur-
ing growth on amino acids (Arg5,6, Bat21, Cpa2, His1, Hom6,
Ilv5, Lys12, and Met6/14/15), and this was also the case during
FIG 1 Impact of carbon source on the C. albicans proteome. (A) Replicate 2D gels showing that Pox4 is more abundant during growth on oleic acid than on
glucose and that Pox4 is retained after 2 h of exposure to glucose. (B)Network ofC. albicans proteins regulated in response to carbon source.Nodes are connected
by edges to the one or more conditions under which it was identified: upregulated2-fold relative to growth on glucose (upward arrowhead); downregulated
2-fold (downward arrowhead). Functions thatwere differentially regulated ondifferent carbon sources (rounded rectangle) have color-coded connecting lines:
green for upregulated and red for downregulated. Functions regulated under all three conditions lie in three blocks in the center of the network interactions.
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growth on lactate (Arg5,6, Bat21, His1, and Met6) or oleic acid
(Arg5,6, Bat21, His1, and Met6) (Fig. 1; Table S2). These data
largely confirmed expectations based on our understanding of
metabolism in other yeasts and the limited experimental data on
C. albicansmetabolic regulation (35, 49). The observed changes in
Pck1 and Icl1 levels were validated by Western blot analysis of
these proteins followingMyc tagging inC. albicans (Fig. 2A). Note
that Icl1 levels were below the limits of detection in the lactate
proteome (Table S2).
The levels of other types of proteinweremodulated in response
to carbon source. These proteins included proteins involved in
growth and cell polarity (Arp2, Cap2, Pfy1, Cof1, Crn1, and
Rbp1), nuclear transport (Ntf2), DNA repair (Rad23), and pro-
tein folding (Pdi1 and Cyp51) (see Table S2 in the supplemental
material). Interestingly, proteins involved in drug resistance
(Pdr13 and Erg13) were also affected by carbon source, which is
consistent with the recent finding that carbon source affects the
antifungal drug resistance of C. albicans (50). Also, a number of
stress functions were affected by carbon source (Table S2). The
levels of Hsp70 family members (Hsp70/Ssa4, Ssa1, and Kar2)
were differentially regulated in response to carbon source. The
Trx1 thioredoxin was also dramatically upregulated during
FIG 2 Effect of carbon source on central carbonmetabolic enzymes inC. albicans. (A)Western blots demonstrating the effects of overnight growth on different
carbon sources on the levels of Myc-tagged Icl1 and Pck1 in C. albicans cells (CA1395 and CA1431 [see Table S1 in the supplemental material]). Control lanes
contain extracts from the untagged parental strain (RM1000) control grown on lactate. (B) Effects of growth on oleic acid versus glucose on the levels of enzymes
involved in central carbon metabolism. All enzymes shown were identified on the 2D gels. The effects of growth on oleic acid versus glucose on the levels of
enzymes are indicated as follows: white, no significant change in the levels of glucose- and oleic acid-grown cells; red, protein level significantly elevated in oleic
acid-grown cells; cyan, protein level significantly elevated in glucose-grown cells. For abbreviations, see the Candida Genome Database (http://www
.candidagenome.org).
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growth on lactate, oleic acid, or amino acids, while the
glutaredoxin-like protein Grx3 was downregulated on lactate and
oleic acid. The levels of catalase glutathione peroxidize (Gpx1)
were also upregulated on lactate. These data were consistent with
the observation that host carbon source affects stress resistance in
C. albicans (50).
Transcript profiling data are available for the effects of glucose
on lactate-grown C. albicans cells (47). We found the correlation
between these transcript profiling data and our proteomic data for
lactate- and glucose-grown cells to be modest at best (correlation
coefficient 0.25) (Fig. 3A). No doubt differential protein stabil-
ities, alterations in posttranslational modifications, and the exis-
tence of multiple 2D gel features for some proteins contributed to
this. Nevertheless, this was consistent with other comparisons of
transcriptomic and proteomic data sets, which vary considerably
in their degree of correlation (51–54).
Differential effects of glucose on theC. albicans proteome in
the short term and longer term.Having tested the impact on the
C. albicans proteome of growth on different carbon sources, we
examined the effects of glucose addition to cells growing on alter-
native carbon sources. A similar experimental approachwas taken
except that C. albicansNGY152 cells were grown for 20 h to mid-
exponential phase on lactate, oleate, or amino acids as the sole
carbon source, and then 2% glucose was added 2 h before the cells
were harvested for proteomic analyses. Once again, proteins that
displayed statistically significant changes across three indepen-
dent experiments (Fig. 1A) were identified by mass spectrometry
(see Table S2 in the supplemental material; PRIDE accession
numbers 3186 to 3192). Principal component analysis indicated
that glucose addition exerted significant effects on the lactate,
oleate, and amino acid proteomes and that these effects were dis-
tinct from long-term growth on glucose (Fig. 1B), although sim-
ilar subsets of proteins were affected (Table S2).
We compared the short- and longer-term effects of glucose on
the C. albicans proteome (Fig. 3B; see Fig. S1 in the supplemental
material). Interestingly, the extent of correlation between the
short- and long-term changes differed for different sets of func-
tionally related proteins. Glycolytic enzymes showed a strong cor-
relation, generally displaying glucose induction in both the short
and longer terms (Fig. 3B). In contrast, gluconeogenic, glycoxylate
cycle, TCA cycle, and fatty acid -oxidation enzymes displayed a
poor correlation. The levels of many of these enzymes were gen-
erally lower in glucose-grown cells, and their levels did not decline
significantly after exposure to glucose for 2 h (Fig. S1).
Icl1 and Pck1 are not subject to catabolite inactivation in
C. albicans. The apparent stability of gluconeogenic and glyoxy-
late cycle enzymes following glucose exposure in C. albicans con-
trasted with observations in S. cerevisiae where glucose triggers
catabolite inactivation of these enzymes (23–25, 31). Therefore,
we examined the impact of glucose on the stability of C. albicans
Icl1 and Pck1 byWestern blotting ofMyc-tagged versions of these
proteins (Fig. 4). C. albicans CA1395 (ICL1-Myc3) and CA1431
(PCK1-Myc3) (see Table S1 in the supplemental material) were
grown to mid-exponential phase in medium containing lactate as
the sole carbon source, and then 2% glucose was added. Protein
extracts were prepared at various times thereafter and subjected to
Western blotting, revealing that Icl1 and Pck1 were stable follow-
ing glucose addition (Fig. 4B). Similar observations were made in
oleic acid-grown cells exposed to glucose (see Fig. S3 in the sup-
plemental material). These data were consistent with our obser-
vation that Icl1 and Pck1 are retained at high levels in C. albicans
cells 2 h after glucose addition (Table S2).
We then measured the stability of the corresponding mRNAs
under equivalent growth conditions by quantitative reverse
transcription-PCR (qRT-PCR) relative to the internal ACT1
mRNA control. The ICL1 and PCK1 mRNAs were rapidly de-
graded following glucose addition to lactate-grown cells (Fig. 4B),
and similar data were obtained for oleic acid-grown cells (see
Fig. S3 in the supplemental material). These observations were
entirely consistent with the results of previous microarray exper-
iments, suggesting that these transcripts are strongly repressed by
glucose in C. albicans (46, 47). Therefore, ICL1 and PCK1 tran-
scription is strongly regulated by glucose, but this regulation is not
reflected in the proteome.
These experiments were replicated in S. cerevisiae to exclude
the possibility that the lack of catabolite inactivation inC. albicans
was an experimental artifact. S. cerevisiae DS1-W10 (ICL1-Myc9)
and DS1-W20 (PCK1-HA6) (see Table S1 in the supplemental
material) were grown on lactate and exposed to 2%glucose, and at
various times thereafter, Icl1 and Pck1 levels were examined by
FIG 3 Comparisons of the C. albicans transcriptome and proteome. (A) The
C. albicans transcriptome and proteome display limited correlation with re-
spect to the observed log fold changes between cells grown on glucose or lactic
acid. The transcriptomic data were taken from reference 47, and proteomic
data were taken from Table S2 in the supplemental material. (B) Correlation
between the short-term and long-term effects of glucose on central metabolic
enzymes. Glycolytic enzymes are shown in blue. Gluconeogenic, glyoxylate
cycle, and tricarboxylic acid (TCA) cycle enzymes are shown in red.
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Western blotting (Fig. 4C). The Icl1 and Pck1 enzymes were stable
in S. cerevisiae in the absence of glucose but were destabilized
following glucose addition. Similar data were obtained for oleic
acid-grown S. cerevisiae cells (see Fig. S3 in the supplemental ma-
terial). These data recapitulate earlier observations (23, 24) and
confirm that these gluconeogenic and glyoxylate cycle enzymes
are subject to catabolite inactivation in S. cerevisiae. Furthermore,
the ICL1 and PCK1 transcripts were rapidly degraded in S. cerevi-
siae following glucose addition (Fig. 4C), confirming earlier re-
ports to this effect (5, 6, 20). Therefore, C. albicans differs signifi-
cantly from S. cerevisiae in that Icl1 and Pck1 are not subject to
catabolite inactivation in response to glucose in the pathogenic
yeast.
C. albicans has retained the apparatus for catabolite inacti-
vation. In principle, the lack of glucose-accelerated degradation of
Icl1 and Pck1 in C. albicans could have been due to the evolution-
ary loss of the catabolite inactivation apparatus in this pathogen.
To test this, we asked whether S. cerevisiae Icl1 is subject to
glucose-accelerated degradation in C. albicans.
C. albicans strains were constructed in which the S. cerevisiae
ICL1 (ScICL1) open reading frame (ORF) was expressed from the
C. albicans ICL1 (CaICL1) promoter at the native ICL1 locus. The
functionality of three-Myc (Myc3)-tagged S. cerevisiae Icl1
(ScIcl1) in C. albicans was first confirmed in DSCO2 cells (icl1/
ScICL1) (see Table S1 in the supplemental material), the ScICL1-
Myc3 gene suppressing the growth defect ofC. albicans icl1 cells on
lactate, oleic acid, pyruvate, and acetate as the sole carbon source
(Fig. 5A). The stability of the Myc3-tagged ScIcl1 was then exam-
ined in lactate-grown C. albicans DSCO1 cells (ICL1/ScICL1-
Myc3). ScIcl1 was stable inC. albicans in the absence of glucose but
was rapidly degraded following glucose addition (Fig. 5B). These
observations were reproducible, and analogous observations were
made in oleic acid-grown C. albicans DSCO1 cells (see Fig. S4 in
the supplemental material). We conclude that ScIcl1 is subject to
glucose-accelerated degradation in C. albicans, and hence that
during evolution C. albicans has retained the apparatus for catab-
olite inactivation.
In this case, has CaIcl1 lost the signal that triggers glucose-
accelerated degradation? The stability of the CaIcl1-Myc3 protein
was assayed in the S. cerevisiae strain DS4-Y40 in which theMyc3-
taggedCaICL1 open reading framewas expressed from the ScICL1
promoter at the native ICL1/YDR477w locus (see Table S1 in the
supplemental material). The CaIcl1-Myc3 protein was stable in
lactate-grown DS4-Y40 cells and was not destabilized by glucose
addition relative to internal loading controls (Fig. 6). Once again,
these observationswere reproducible, and analogous observations
were made for oleic acid-grown S. cerevisiae DS4-Y40 cells (see
Fig. S4 in the supplementalmaterial). Therefore, CaIcl1 appears to
have lost the signal that triggers glucose-accelerated degradation.
Ubiquitination contributes to glucose-accelerated protein
degradation in C. albicans. Ubiquitination contributes to
glucose-mediated protein destabilization in S. cerevisiae (28, 32).
Therefore, we tested whether ubiquitination contributes to
glucose-accelerated degradation of ScIcl1 in C. albicans. The
ScICL1-Myc3 cassette was integrated at the native ICL1 locus in a
C. albicans ubi4mutant that lacks polyubiquitin.Ubiquitination is
significantly reduced in this ubi4mutant, residual ubiquitin being
expressed only from the UBI3 locus (55). The stability of the
ScIcl1-Myc3 protein in these C. albicans DSCO3 cells (ubi4/ubi4
ICL1/ScICL1-Myc3) (see Table S1 in the supplemental material])
was compared to ScIcl1-Myc3 stability in DSCO1 cells (UBI4/
UBI4 ICL1/ScICL1-Myc3) and the stability of the CaIcl1-Myc3
protein in CA1395 cells (UBI4/UBI4 ICL1/ICL1-Myc3). ScIcl1-
Myc3 and CaIcl1-Myc3 were stable in these strains during growth
FIG 4 Icl1 and Pck1 protein stability and ICL1 and PCK1mRNA turnover in
C. albicans and S. cerevisiae following the addition of glucose. (A) CaIcl1-Myc
and CaPck1-Myc protein levels were measured byWestern blotting at various
times after the addition of glucose to C. albicans cells grown on lactate. (B)
CaIcl1-Myc and CaPck1-Myc were quantified by Western blotting relative to
the Act1 internal control following glucose addition. Also CaICL1 and
CaPCK1 mRNA levels were assayed in the same cultures by qRT-PCR and
compared to the level in the ACT1mRNA internal control after glucose addi-
tion. The relative levels of these mRNAs and proteins were expressed as a
percentage of their abundance at time zero, which was set at 100%. (C) ScIcl1-
Myc and ScPck1-HA protein levels were measured by Western blotting, and
ScICL1 and ScPCK1 mRNA levels were assayed by qRT-PCR in S. cerevisiae
cells grown on lactate and exposed to glucose at time zero. The relative levels of
these mRNAs and proteins were expressed as a percentage of their abundance
at time zero (whichwas set at 100%): circles, Icl1; squares, Pck1; black symbols,
Icl1 and Pck1 proteins in lactate-grown cells after glucose addition; gray sym-
bols, Icl1 and Pck1 proteins in control lactate-grown cells with no glucose
addition; open symbols, ICL1 and PCK1 mRNAs in lactate-grown cells after
glucose addition. Similar data were obtained from two independent replicate
experiments.
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on lactate in the absence of glucose (not shown). Once again,
ScIcl1-Myc3 was destabilized following glucose addition to wild-
type DSCO1 cells (Fig. 7). However, ScIcl1-Myc3 was partially
stabilized in the polyubiquitin mutant, suggesting that glucose-
accelerated degradation of ScIcl1 in C. albicans is at least partially
dependent upon ubiquitination. This observation was reproduc-
ible in independent experiments, and furthermore, similar obser-
vationsweremadewhen the same strains were grown on oleic acid
rather than lactate (see Fig. S5 in the supplemental material). The
residual ScIcl1-Myc3 destabilization observed in lactate- or oleic
acid-grown ubi4 cells could have been due either to the involve-
ment of a second degradation pathway in this response (28) or to
the residual ubiquitination that is observed in the C. albicans
polyubiquitinmutant (55).We conclude that ubiquitination con-
tributes to glucose-accelerated protein degradation in C. albicans.
FIG 5 ScIcl1 is functional in C. albicans and rapidly degraded in response to
glucose. (A) Expression of ScICL1 in C. albicans suppresses the carbon source
conditional phenotypes of an icl1mutant: ICL1,C. albicansCA510 (ICL1/icl1)
(see Table S1 in the supplemental material); icl1, C. albicans CA517 (icl1/icl1);
ScICL1,C. albicansDSCO1 (ScICL1/icl1). (B) Impact of glucose on the levels of
the ScIcl1-Myc protein expressed in lactate-grown C. albicans DSCO1 cells
relative to the abundance at time zero. (Top) Western blotting of ScIcl1-Myc
levels. (Bottom) Quantification of ScIcl1-Myc levels expressed as a percentage
of the abundance at time zero (100%): closed symbols, plus glucose; open
symbols, control cells lacking glucose. Similar data were obtained from two
independent replicate experiments.
FIG 6 CaIcl1 is stable in S. cerevisiae following the addition of glucose.
CaICL1-Myc3 was expressed in S. cerevisiae DS4-Y40 cells (see Table S1 in the
supplemental material) grown on lactate, and CaIcl1-Myc protein levels were
assayed by Western blotting after glucose addition. CaIcl1-Myc levels are ex-
pressed as a percentage of the abundance at time zero (which was set at 100%):
closed symbols, plus glucose; open symbols, control cells lacking glucose. Sim-
ilar data were obtained from two independent replicate experiments.
FIG 7 Inactivation of polyubiquitin inhibits glucose-accelerated ScIcl1 deg-
radation in C. albicans. ScICL1-Myc3 was expressed in C. albicans DSCO3
(ubi4/ubi4) (see Table S1 in the supplementalmaterial) andDSCO1 (wild type
[wt]) (UBI4/UBI4) cells grown on lactate, and then ScIcl1-Myc protein levels
were assayed after the addition of glucose by Western blotting. For a control,
CaIcI1-Myc levels were assayed in C. albicans DSCO3 (ubi4/ubi4) cells grown
on lactate and following glucose addition. ScIcl1-Myc and CaIcl1-Myc levels
are expressed as a percentage of their abundance at time zero (which was set at
100%). Similar data were obtained from two independent replicate experi-
ments.
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C. albicans Icl1 lacks ubiquitination sites that trigger
glucose-accelerated protein degradation. Why does CaIcl1 es-
cape glucose-accelerated ubiquitin-mediated protein degrada-
tion?We screened for consensus ubiquitination target sites in Ca-
Icl1 and ScIcl1 using UbPred (predictor of protein ubiquitination
sites) (http://www.ubpred.org/index.html) (56). The UbPred
software, which was trained on 272 ubiquitination sites in
S. cerevisiae, predicts ubiquitination sites based on numerous
properties of the target amino acid sequence, including the net
and total charge, aromatic content, charge/hydrophobicity ratio,
sequence complexity, flexibility, amphipathic moment, and in-
trinsic disorder (56). The ScIcl1 andCaIcl1 proteins display strong
amino acid sequence similarity (78% similarity and 67% identity).
Yet while ScIcl1 contains two strong consensus ubiquitination
sites at residues 158 and 551 according to UbPred, CaIcl1 carries
no high-confidence ubiquitination targets (Fig. 8A). Therefore,
we reasoned that the lack of such a ubiquitination site protected
CaIcl1 from glucose-accelerated degradation.
To test this, we fused the carboxy-terminal ubiquitination site
from ScIcl1 onto the carboxy terminus of CaIcl1 along with a
Myc3 epitope tag and then compared the stability of this CaIcl1-
Ubi-Myc3 protein with control CaIcl1-Myc3 and ScIcl1-Myc3
proteins in C. albicans. The stabilities of these proteins were first
measured in mid-exponential C. albicans CA1395 (ICL1/ICL1-
Myc3), DSCO1 (ICL1/ScICL1-Myc3), and DSCO4 (ICL1/ICL1-
Ubi-Myc3) cells grown on lactate. All of the proteins were stable
under these conditions (not shown). Once again, ScIcl1-Myc3 was
destabilized following glucose addition, whereas CaIcl1-Myc3 re-
mained stable (Fig. 8B). Interestingly, the CaIcl1-Ubi-Myc3 pro-
tein was reproducibly destabilized following glucose addition.
Furthermore, analogous observations were made in C. albicans
CA1395,DSCO1, andDSCO4 cells grownonoleic acid (see Fig. S6
in the supplemental material). Therefore, the addition of a ubiq-
uitination site was sufficient to trigger glucose-accelerated degra-
dation of the normally stable CaIcl1-Myc3 protein in C. albicans.
These observations reinforced the view that C. albicans has re-
tained the apparatus for glucose-accelerated protein degradation
and suggested that the lack of an appropriate ubiquitination site in
CaIcl1 prevents this protein from entering this degradation path-
way.
C. albicans continues to assimilate alternative carbon
sources following glucose exposure. Is this evolutionary rewiring
of ubiquitination targets between C. albicans and S. cerevisiae re-
flected in the metabolic activities of these yeasts? To test this, we
compared [14C]lactate assimilation by mid-exponential C. albi-
cans RM1000 and S. cerevisiaeW303-1B cells that were grown on
lactate in the presence and absence of glucose (Fig. 9). As expected,
the presence of glucose inhibited the assimilation of [14C]lactate
by S. cerevisiae. However, glucose did not inhibit [14C]lactate by
C. albicans over the 4-h period examined, which was consistent
with the retention by this pathogen of glyoxylate cycle and gluco-
neogenic enzymes after glucose addition. These reproducible ob-
servations were reinforced by analogous data on oleic acid assim-
ilation by oleic acid-grown C. albicans and S. cerevisiae cells.
Glucose inhibited [3H]oleic acid assimilation in S. cerevisiae
W303-1B cells, but not in C. albicans RM1000 cells (see Fig. S7 in
the supplemental material). These data indicate that, unlike
S. cerevisiae, C. albicans continues to assimilate alternative carbon
sources after exposure to glucose.
FIG 8 Addition of a consensus ubiquitin site stimulates glucose-accelerated
degradation of CaICl1 inC. albicans. (A) Schematic representation illustrating
the existence of high-confidence ubiquitination sites in ScIcl1 and the lack of
such sites in CaIcl1 as predicted by UbPred (http://www.ubpred.org/index
.html) (56). (B) The carboxy-terminal ubiquitination site from ScIcl1 was
fused to CaIcl1 to create CaIcl1-Ubi-Myc in C. albicans DSCO4 (see Table S1
in the supplementalmaterial). These cells were grown on lactate, and the levels
of CaIcl1-Ubi-Myc were assayed by Western blotting after the addition of
glucose. For controls, the stabilities of CaIcl1-Myc (CA1395) and ScIcl1-Myc
(DSCO1) (gray squares) in C. albicans were compared under equivalent con-
ditions. CaIcl1-Ubi-Myc, ScIcl1-Myc, andCaIcl1-Myc levels are expressed as a
percentage of their abundance at time zero (which was set at 100%). Similar
data were obtained from two independent replicate experiments.
FIG 9 Glucose does not inhibit lactate assimilation by C. albicans. Exponen-
tial C. albicans RM1000 and S. cerevisiae W303-1B cells (see Table S1 in the
supplemental material) grown on lactate were suspended in fresh medium
containing [14C]lactate and 2% glucose (gray bars) or with no glucose (black
bars). The assimilation of radiolabeled lactate by cells was assayed at various
times thereafter (Materials and Methods). Similar data were obtained from
two independent replicate experiments.
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DISCUSSION
The prevailing view is that C. albicans fits the S. cerevisiae para-
digm with regard to the impact of glucose upon central carbon
metabolism. This influences current thinking about nutrient ad-
aptation during infection and host-fungus interactions (46, 47,
57). However, this view does not resonate well with the evolution
of these yeasts in contrasting niches that differ significantly with
regard to carbon source availability (40) and with an early report
that C. albicans is a Crabtree-negative yeast (48). We now show
that, despite the similar effects that glucose exerts on the C. albi-
cans and S. cerevisiae transcriptomes (46, 47), these yeasts display
fundamental differences in the effects of glucose on central meta-
bolic functions and carbon assimilation. The levels of many glu-
coneogenic, glyoxylate cycle, and fatty acid -oxidation enzymes
do decline in C. albicans after protracted growth on glucose, and
the changes in the proteomic network (Fig. 1) reflect those ob-
served previously during a comprehensive comparison of
exponential- and stationary-phaseC. albicans cells (58). However,
these enzymes are stable during short-term exposure to glucose
(Fig. 2 and 4; see Table S2 in the supplemental material), and this
allowsC. albicans cells to continue to assimilate alternative carbon
sources even in the presence of glucose, unlike S. cerevisiae (Fig. 9).
Our analyses of Icl1 and Pck1 turnover have suggested that
enzymes involved in the assimilation of alternative carbon sources
are retained in C. albicans following glucose addition because
these enzymes remain stable while their transcripts are degraded
(Fig. 4). We show that this contrasts with S. cerevisiae cells that
degrade these enzymes following glucose addition and their tran-
scripts (Fig. 4). It is conceivable that carboxy-terminal tagging of
CaIcl1 and ScIcl1 affected their localization and stability. Never-
theless, our data were consistent with the study of López-Boado et
al. (24) who reported that Icl1 is subject to catabolite inactivation
in S. cerevisiae.We then showed that, although CaIcl1 and CaPck1
are not subjected to glucose-accelerated protein degradation in
C. albicans, this pathogen has retained the molecular apparatus to
execute this function, as ScIcl1 is degraded following glucose ad-
dition when expressed as a functional enzyme in C. albicans
(Fig. 5). Rather, CaIcl1 lacks the signal that triggers glucose-
accelerated protein degradation in S. cerevisiae (Fig. 6).
Ubiquitin-dependent mechanisms contribute to the catabolite
inactivation of Fbp1 in S. cerevisiae (28), and protein ubiquitina-
tion is known to be important for nutrient adaptation as well as
growth, morphogenesis, and stress responses in C. albicans (55,
59–64). Therefore, we reasoned that ubiquitination might also
contribute to glucose-accelerated protein degradation in C. albi-
cans and that CaIcl1 might lack critical ubiquitination sites re-
quired to target this protein for catabolite inactivation. Three ob-
servations support this hypothesis. First, the inactivation of
polyubiquitin (Ubi4) lowered the rate of ScIcl1 degradation in
C. albicans (Fig. 7). ScIcl1 degradationwas not completely blocked
because the UBI3 gene would provide residual ubiquitin in C. al-
bicans ubi4 cells (55, 65). Second, in silico analyses of the ScIcl1 and
CaIcl1 sequences revealed that while ScIcl1 contains two high-
confidence ubiquitination sites, CaIcl1 contains none (Fig. 8A)
despite these proteins displaying a high degree of overall sequence
identity (67%). Third, the addition of a carboxy-terminal ubiq-
uitination site to the CaIcl1 protein was sufficient to program this
protein for glucose-accelerated protein degradation in C. albicans
(Fig. 8). Therefore, during the evolution ofC. albicans, this patho-
gen has retained the molecular apparatus that mediates glucose-
accelerated protein degradation, and CaIcl1 has evolved to escape
this process.
Our proteomic analyses indicate that other C. albicans en-
zymes involved in the assimilation of alternative carbon sources
lack ubiquitination sites are retained following glucose exposure
(Fig. 3B; see Table S1 in the supplementalmaterial). Furthermore,
our in silico comparisons have suggested that enzymes specific for
gluconeogenesis and the glyoxylate cycle lack the requisite ubiq-
uitination sites required for glucose-accelerated protein degrada-
tion. S. cerevisiae malate synthase (ScMls1) contains three low-
confidence ubiquitination sites according to UbPred (http://www
.ubpred.org/index.html) (56), whereas CaMls1 contains no
putative ubiquitination sites. UbPred also predicts that both
ScFbp1 and ScPck1 contain high-confidence ubiquitination sites,
whereas CaFbp1 and CaPck1 do not. This was consistent with our
observation that, following glucose addition, ScPck1 is degraded
in S. cerevisiae, but CaPck1 is not degraded in C. albicans (Fig. 4).
Meanwhile, our previous work has indicated that a number of
glycolytic enzymes are ubiquitinated in C. albicans (55). There-
fore, significant evolutionary rewiring of ubiquitination targets
appears to have occurred in this pathogen, allowing it to assimilate
alternative carbon sources in the presence of glucose, unlike
S. cerevisiae (Fig. 9).
These observations have several important implications for
our understanding of C. albicans as a pathogen. First, our data
indicate that under some conditions there is significant disloca-
tion between the transcriptome andproteome.Microarray studies
have contributed significantly to our understanding of C. albicans
pathobiology (43, 44, 46, 66–68), and it is frequently presumed
that changes in the transcriptome are reflected in corresponding
changes in the C. albicans proteome and physiology. In some
cases, there is a good correlation between the transcriptome and
proteome, for example with regard to the induction of glycolytic
enzymes in response to glucose (Fig. 3) and during amino acid
starvation (54). However, this is not always the case (69), and this
study demonstrates clearly that caution is required inmaking pre-
sumptions about the proteome based on the transcriptome. In-
deed, this explains the conundrum as to why C. albicans is a
Crabtree-negative yeast (48) even though its transcriptome is ex-
quisitely sensitive to glucose (47). Thankfully, many studies pro-
vide experimental confirmation of working hypotheses on the ba-
sis of their microarray observations.
The second important implication relates to fungal nutrient
assimilation during colonization and disease progression. C. albi-
cans occupies dynamic host niches that contain complexmixtures
of carbon sources that change over time through a combination of
host and fungal metabolic activities. Many niches contain mini-
mal sugar concentrations (e.g., the urogenital tract), while in oth-
ers,C. albicans is transiently exposed to sugars (e.g., the oral cavity
and gastrointestinal tract). This opportunistic pathogen probably
evolved in niches such as these. Also, the evidence suggests that a
proportion of C. albicans cells that infect internal organs actively
assimilate alternative carbon sources rather than sugars (40, 70).
Furthermore, lactate assimilation is essential for the proliferation
of C. glabrata in the intestine (38). Our data now suggest that
transient exposure to sugar does not prejudice the assimilation of
alternative carbon sources and, as a result, the growth of the fun-
gus in these niches. This explains why both gluconeogenic and
glycolytic functions can be expressed in C. albicans cells infecting
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the kidney (40) and why mutations that block gluconeogenesis or
the glyoxylate cycle partially attenuate the virulence of C. albicans
(39–42). Clearly, C. albicans does not conform to the S. cerevisiae
paradigm of glucose regulation, and this is important for the
pathogenicity of this yeast.
MATERIALS AND METHODS
Strains and growth conditions. C. albicans and S. cerevisiae strains (see
Table S1 in the supplemental material) were grown at 30°C in minimal
medium (0.67% yeast nitrogen base) containing glucose (2%) (SD), lactic
acid (2%), oleic acid (0.2%), ormixed amino acids (2%) as the sole carbon
source (71).
Strain construction. C. albicans strains expressing Icl1-Myc3
(CA1395) or Pck1-Myc3 (CA1431) were made by PCR amplification of a
Myc3-URA3 cassette and transforming these products into C. albicans
RM1000 (see Table S1 in the supplemental material). Insertion at the
correct locus was confirmed by diagnostic PCR, and expression of Icl1-
Myc3 andPck1-Myc3was confirmedbyWestern blotting. Analogous con-
trols were performed for all the following strain constructions.
To replace a CaICL1 allele in C. albicans with a Myc3-tagged ScICL1
open reading frame (ORF) from S. cerevisiae, the ScICL1 locus was first
Myc3 tagged by PCR amplifying the Myc3-URA3 cassette with primers
DS_3F (F stands for forward) and DS_3R (R stands for reverse) (see Ta-
ble S3 in the supplemental material) and transforming this cassette into
S. cerevisiaeBY4743 to create strainDS3-Y30 (Table S1). The new ScICL1-
Myc3-URA3 locus was then PCR amplified using primers DS_5F and
DS_5R, and this CaICL1p-ScICL1-MYC3-URA3 cassette was then trans-
formed into C. albicans RM1000 to create strain DSCO1 (CaICL1/
CaICL1p-ScICL1-MYC3-URA3) (Table S1) and also transformed into
C. albicans CA510 to create strain DSCO1 (Caicl1/CaICL1p-ScICL1-
MYC3-URA3) (Table S1).
To introduce the CaICl1-ScICL1-Myc3-URA3 allele into the C. albi-
cans ubi4/ubi4 background (55), the CaICl1-ScICL1-Myc3-URA3 cassette
was PCR amplified using the DS_5F and DS_5R primers (see Table S3 in
the supplemental material) and transformed into C. albicans DSCO to
create strain DSCO3 (ubi4/ubi4 CaICL1/CaICl1-ScICL1-Myc3-URA3)
(Table S1).
C. albicans DSCO4 expresses CaIcl1 with the carboxy-terminal ubiq-
uitination site from ScIcl1 at its carboxy terminus (CaICL1/CaICl1-Ubi-
Myc3-URA3) (see Table S1 in the supplemental material). This was
achieved by PCR amplifying the 3= end of the ScICL1ORF along with the
conjoined MYC3-URA3 sequences from S. cerevisiae DSCO3 cells using
the DS_6F and DS_6Rprimers (Table S3) and transforming this CaICl1-
Ubi-Myc3-URA3 cassette into C. albicans RM1000.
The ScICL1 and ScPCK1 loci were epitope tagged in S. cerevisiae.
ScICL1 was tagged with Myc9 at its 3= end by PCR amplification of the
MYC9-NAT cassette in pYM21 (72) with primers DS_1F and DS_1R (see
Table S3 in the supplemental material) and transformation of S. cerevisiae
W303-1B to generate strain DS1-W10 (ScICL1-MYC9-NAT) (Table S1).
ScPCK1 was tagged with hemagglutinin (a six-hemagglutinin tag [HA6])
by PCR amplification of the HA6-KlTRP1 (KlTRP1 stands for Kluyvero-
myces lactis TRP1) cassette in pYM3 (73) with primers DS_2F and DS_2R
(Table S3) and transformation of S. cerevisiae W303-1B to create strain
DS1-W20 (ScPCK1-HA6-KlTRP1) (Table S1).
The ScICl1 ORF in S. cerevisiae BY4743 was replaced with CaICL1-
Myc3 to create the S. cerevisiae strain DS4-Y40 (ScICl1-CaICL1-Myc3-
URA3) (see Table S1 in the supplemental material). The CaICL1-Myc3-
URA3ORF was PCR amplified from C. albicans CA1395 (Table S1) using
the DS_4F and DS_4R primers (Table S3).
Proteomics.Replicate cultures ofC. albicansNGY152 (CAI4 contain-
ing CIp10 [74]) were grown in minimal medium containing glucose
(2%), lactic acid (2%), oleic acid (0.2%), or mixed amino acids (2%) as
the sole carbon source. Samples from the cultures were taken, then sub-
cultured in the same medium, grown for a further 20 h, and harvested in
exponential phase (optical density at 600 nm [OD600] of 0.8). Glucose
(2%) was added to some cultures, and the cells were harvested after 2 h.
Protein extracts were prepared, subjected to 2D gel electrophoresis, and
stained with Coomassie blue as described previously (54). Independent
triplicate experiments were done for each growth condition. Gel features
were compared using Phoretix 2D Expression (Nonlinear Dynamics,
Newcastle upon Tyne, United Kingdom) andGeneSpring (Silicon Genet-
ics, San Carlos, CA). Principal component analysis scores were plotted in
3D (SIMCA-P version 11.0: Umetrics AB, Sweden). Proteins displaying
statistically significant differences in mean spot volume (P  0.05) were
identified by MALDI-ToF mass spectrometry of tryptic peptides (54) us-
ing MS-Fit and MASCOT (Matrix Science, Boston, MA). Protein anno-
tations were from the Candida Genome Database (http://www
.candidagenome.org/). The proteomic data set is available in the
supplemental material (see Table S2 in the supplemental material) and at
the PRIDE proteomic data repository (http://www.ebi.ac.uk/pride/) (ac-
cession numbers 3186 to 3192). The carbon source network was con-
structed using Cytoscape version (http://www.cytoscape.org/) (75).
Western blotting. Protein extracts were subjected toWestern blotting
as described previously (76). Membranes were probed with a mouse anti-
Myc antibody (diluted 1:10,000) (Sigma). The secondary antibody was
peroxidase-conjugated rabbit anti-mouse IgG. Signals were detected with
an enhanced chemiluminescence (ECL)Western blotting kit (Amersham,
United Kingdom) and quantified using a Fuji FLA-3000 imager.
RNA analyses. RNA was prepared (77, 78), yields were quantified
using an RNA 6000 Nano assay, and RNA integrity was assessed using an
Agilent 2100 bioanalyzer (79). ICL1 and PCK1 transcript levels were
quantified to the internal ACT1 mRNA by qRT-PCR using primers (see
Table S3 in the supplemental material). RNA samples (2 g) were incu-
bated in 20-l reactions with DNase I (1.5 l), RNase OUT (1.5 l), and
DNase I buffer (2l) (Invitrogen, UnitedKingdom) at room temperature
for 15min. cDNAwas thenmadewith SuperScript II reverse transcriptase
(Invitrogen, United Kingdom) following the manufacturer’s protocols.
Real-timeRT-PCR SYBR green (Roche, UnitedKingdom)was performed
using the manufacturer’s instructions with a LightCycler 480 real-time
PCR system (Roche).
Lactate and oleic acid assimilation. Lactate and oleic acid assimila-
tion was assayed by measuring the incorporation by C. albicans and
S. cerevisiae of [14C]lactate and [3H]oleic acid into trichloroacetic acid-
precipitable material. Yeast cells were grown on YPLactate (2% Bacto
peptone and 1% yeast extract containing 2% lactate) or YPOleic acid (2%
Bacto peptone and 1% yeast extract containing 0.2% oleic acid) at 30°C to
an OD600 of 1, harvested, and resuspended in 1 ml fresh prewarmed YP-
Lactate or YPOleic acid. Glucose (2%) was added to half of the cells, and
no glucose was added to control cells. Then, 1.85 MBq of [14C]lactic acid
or 37 MBq of [3H]oleic acid was added at time zero, and samples were
taken at various times thereafter. The samples were precipitated in 5%
trichloroacetic acid at 0°C, washed at 0°C in a series of solutions [(i) fresh
5% trichloroacetic acid containing 0.1% SDS, (ii) 50% ethanol, and (iii)
100% ethanol], dried, and subjected to scintillation counting (Packard
BioScience). The results are means and standard deviations from tripli-
cate assays. Similar results were obtained in triplicate independent exper-
iments.
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